Close Menu
NEW YORK – Chinese precision oncology company Genetron Health has formed a strategic partnership with Beijing InnoCare Pharma Tech (InnoCare) to provide clinical trial genomic testing and companion diagnostic development services for InnoCare's biomarker-driven oncology drug development.
 
Additional details of the agreement were not disclosed.
 
Genetron, based in Beijing, provides comprehensive genomic profiling services for drug research and development.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.